Elevated expression of integrin αIIb βIIIa in drug-naïve, first-episode schizophrenic patients

Biological Psychiatry

Volumn 52, Issue 9, 2002, Pages 874-879

  Walsh, Marie T Hérèse ^a   Ryan, Martina ^a,b   Hillmann, Andrew ^a,b   Condren, Rita ^a,b   Kenny, Dermot ^c   Dinan, Timothy ^c   Thakore, Jogin H ^d  

^a BEAUMONT HOSPITAL   (Ireland)

^b St Vincent's Hospital Ireland   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d Department of Pharmacology and Therapeutics   (Ireland)

Author keywords

Aggregation; Antipsychotic medication; Coagulation cascade; Integrin; Platelets; Schizophrenia

Indexed keywords

ADENOSINE DIPHOSPHATE; CD63 ANTIGEN; GLYCOPROTEIN IB; INTEGRIN; INTEGRIN ALPHA2B BETA3A; PADGEM PROTEIN; PROTEIN SUBUNIT; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHIATRIC DIAGNOSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

ADENOSINE DIPHOSPHATE; ADULT; AGED; ANTIGENS, CD; ANTIGENS, SURFACE; CARDIOVASCULAR DISEASES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEIN IIB; PLATELET MEMBRANE GLYCOPROTEINS; RISK FACTORS; SCHIZOPHRENIA, PARANOID;

EID: 0036839123     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01400-2     Document Type: Article

References (59)

1. Allebeck P. Schizophrenia A life-shortening illness . Schizophr Bull. 15:1989;81-89.
2. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC: American Psychiatric Press.
3. Andrews R.K., Berndt M.C. Adhesion-dependent signaling and the initiation of haemostasis and thrombosis. Histol Histopathol. 13:1998;837-844.
4. Basani R.B., Vilaire G., Shattil S.J., Kolodziej M.A., Bennett J.S., Poncz M. Glanzmann thrombasthenia due to a two amino acid deletion in the fourth calcium-binding domain of alpha IIb Demonstration of the importance of calcium-binding domains in the conformation of alpha IIb beta 3 . Blood. 88:1996;167-173.
5. Berk M., Plein H., Csizmadia T. Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia. Int Clin Psychopharmacol. 14:1999;119-122.
6. Bhatt D.L., Topol E.J. Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease. Med Clin North America. 84:2000;163-179.
7. Black D.W. Iowa record-linkage study Death rates in psychiatric patients . J Affect Disord. 50:1998;277-282.
8. Black D.W., Fisher R. Mortality in DSM-IIIR schizophrenia. Schizophren Res. 7:1992;109-116.
9. Block K.L., Poncz M. Platelet glycoprotein IIb gene expression as a model of megakaryocyte-specific expression. Stem Cells. 13:1995;135-145.
10. Borcsiczky, Tekes K., Tarcali J., Meszaros Z., Faludi G., Mathe M., et al. Platelet rich plasma serotonin content in patients suffering from different psychiatric disorders. Acta Physiol Hung. 84:1996;403-404.
11. Bray P.F., Barsh G., Rosa J.P., Luo X.Y., Magenis E., Shuman M.A., et al. Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa. Proc Natl Acad Sci U S A. 85:1988;8683-8687.
12. Brown S. Excess mortality of schizophrenia A meta-analysis . Br J Psychiatry. 171:1997;502-508.
13. Brown S., Birtwhistle J., Roe L., Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med. 29:1999;697-701.
14. Brown S., Inskip H., Barralough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 177:2000;212-217.
15. Chang Y.S., Seldin M.F., Fitzgerald L.A., Lalley P.A. Conservation of the linkage of the murine Itga2b and Itgb3 loci in mouse chromosome 11. Mamm Genome. 10:1999;530-531.
16. Das I., Khan N.S. Increased arachidonic acid induced platelet chemiluminescence indicates cyclooygenase overactivity in schizophrenic subjects. Prostaglandins Leukot Essent Fatty Acids. 58:1998;165-168.
17. Dinan T.G. Neuroleptic effects on platelet aggregation A study in normal volunteers and schizophrenics . Psychol Med. 17:1987;875-881.
18. Doubeikovski A., Uzan G., Doubeikovski Z., Prandini M.H., Porteu F., Gisselbrecht S., et al. Thrombopoietin-induced expression of the glycoprotein IIb gene involves the transcription factor PU.1/Spi-1 in UT7-Mpl cells. J Biol Chem. 272:1997;24300-24307.
19. Escolar G., White J.G. Changes in glycoprotein expression after platelet activation Differences between in vitro and in vivo studies . Thromb Haemost. 83:2000;371-386.
20. Godin G., Shephard R.J. A simple method to assess exercise behaviour in the community. Can J Appl Sports Sciences. 10:1985;141-146.
21. Goldman L.S. Medical illness in patients with schizophrenia. J Clin Psychiatry. 21:1999;10-15.
22. Guy W (1976): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education and Welfare, pp. 534-537.
23. Harris E.C., Barraclough B. Excess mortality of mental disorders. Br J Psychiatry. 173:1998;11-53.
24. Jakovljevic M., Muck-Seler D., Pivac N., Ljubicic D., Bujas M., Dodig G. Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia. Biol Psychiatry. 41:1997;1028-1034.
25. Janes S.L., Kyle P.M., Redman C., Goodall A.H. Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thromb Haemost. 74:1995;1059-1063.
26. Janes S.L., Wilson D.J., Chronos N., Goodall A.H. Evaluation of whole blood flow cytometric detection of platelet bound fibrinogen on normal subjects and patients with activated platelets. Thromb Haemost. 70:1993;659-666.
27. Kahn M.J., Kieber-Emmons T., Vilaire G., Murali R., Poncz M., Bennett J.S. Effect of mutagenesis of GPIIb amino acid 273 on the expression and conformation of the platelet integrin GPIIb-IIIa. Biochemistry. 35:1996;14304-14311.
28. Kaiya H. Prostaglandin Eqn. 1 suppression of platelet aggregation response in schizophrenia. Schizophren Res. 5:1991;67-80.
29. Kaiya H., Imai H., Muramatsu Y., Nozaki M., Fijimura H., Adachi S., et al. Platelet aggregation response in schizophrenia and prostaglandin Eqn. 1. Psychiatry Res. 9:1983;309-318.
30. Kestin A.S., Ellis P.A., Barnard M.R., Errichetti A., Rosner B.A., Michelson A.D. Effect of strenuous exercise on platelet activation state and reactivity. Circulation. 88:1993;1502-1511.
31. Koller C.F. The role of glycoprotein IIb/IIIa inhibition in the management of acute coronary syndromes. Heart Lung. 30:2001;321-329.
32. Koran L.M., Sox H.C., Marton K.I., Moltzen S., Sox C.H., Kraemer H.C., et al. Medical evaluation of psychiatric patients. 1. Results in a state mental health system. Arch Gen Psychiatry. 46:1989;733-740.
33. Lindahl T.L., Festin R., Larsson A. Studies of fibrinogen binding to platelets by flow cytometry An improved method for studies of platelet activation . Thromb Haemost. 68:1992;221-225.
34. Litjens P.E., Akkerman J.W., van Willigen G. Platelet integrin alpha IIb beta 3 Target and generator of signaling . Platelets. 11:2000;310-319.
35. Maguire K., Cheung P., Crowley K., Norman T., Schweitzer I., Burrows G. Aggressive behaviour and platelet 3H paroxetine binding in schizophrenia. Schizophr Res. 23:1997;61-67.
36. Makikyro T., Karvonen J.T., Hakko H., Nieminen P., Joukamen M., Isohanni M., et al. Comorbidity of hospital-treated psychiatric and physical disorders with special reference to schizophrenia A 28 year follow-up of the 1966 northern Finland general population birth cohort . Public Health. 112:1998;221-228.
37. Modai I., Gibel A., Rauchverger B., Ritsner M., Klein E., Ben-Shachar D. Paroxetine binding in aggressive schizophrenic patients. Psychiatry Res. 94:2000;77-81.
38. Moran N., Morateck P.A., Deering A., Ryan M., Montgomery R.R., Fitzgerald D.J., et al. Surface expression of glycoprotein Iba is dependent on glycoprotein Ibb Evidence from a novel mutation causing Bernard-Soulier syndrome . Blood. 96:2000;532-539.
39. Mortensen P.B., Juel K. Mortality and cause of death in first admitted schizophrenic patients. Br J Psychiatry. 163:1993;183-189.
40. Nurden P., Humbert M., Piotrowicz R.S., Bihour C., Poujol C., Nurden A., et al. Distribution of ligand-occupied alpha IIb beta 3 in resting and activated human platelets determined by expression of a novel class of ligand-induced binding sites recognized by monoclonal antibody AP6. Blood. 88:1996;887-899.
41. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychol Rep. 10:1962;799-812.
42. Parise L.V. Integrin alpha (IIb) beta (3) signaling in platelet adhesion and aggregation. Curr Opin Cell Biol. 11:1999;597-601.
43. Payastre B., Missy K., Trumel C., Bodin S., Plantavid M., Chapter H. The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem Pharmacol. 60:2000;1069-1074.
44. Phelan M., Stradins L., Morrison S. Physical health of people with severe mental illness. Br Med J. 322:2001;443-444.
45. Philips R.J. Physical disorder in 164 consecutive admissions to a mental hospital The incidence and significance . BMJ. 2:1934;363-366.
46. Prandini M.H., Martin F., Thevenon D., Uzan G. The tissue-specific transcriptional regulation of the megakaryocytic glycoprotein IIb gene is controlled by interactions between a repressor and positive cis-acting elements. Blood. 88:1996;2062-2070.
47. Ripova D., Strunecka A., Nemcova V., Farska I. Phospholipids and calcium alterations in platelets of schizophrenic patients. Physiol Res. 46:1997;59-68.
48. Ripova D., Strunecka A., Platilova V., Hoschl C. Phosphoinositide signaling system in platelets of schizophrenic patients and the effect of neuroleptic therapy. Prostaglandins Leukot Essent Fatty Acids. 61:1999;125-129.
49. Roe L., Strong C., Whiteside C., Neil A., Mant D. Dietary intervention in primary care Validity of the DINE method of diet assessment . Fam Pract. 11:1994;375-381.
50. Ruschena D., Mullen P.E., Burgess P., Cordner S.M., Barry-Walsh J., Drummer O.H., et al. Sudden death in psychiatric patients. Br J Psychiatry. 172:1998;331-336.
51. Salame M., Verheye S., More R., King S.B. 3rd, Chronos N. GPIIBIIIa inhibitors as adjunctive therapy in acute myocardial infarction. Int J Cardiol. 69:1999;231-236.
52. Strunecka A., Ripova D. What can investigation of phosphoinositide signaling system in platelets of schizophrenic patients tell us? Prostaglandins Leukot Essent Fatty Acids. 61:1999;1-5.
53. Suzuki H., Nakamura S., Itoh Y., Tanaka T., Yamazaki H., Tanoue K. Immunocytochemical evidence for the translocation of alpha-granule membrane glycoprotein IIb/IIIa (integrin alpha IIb beta 3) of human platelets to the surface membrane during the release reaction. Histochemistry. 97:1992;381-388.
54. Tardito D., Tura G.B., Bocchio L., Bignotti S., Pioli R., Racagni G., et al. Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients. Neuropsychopharmacology. 23:2000;216-219.
55. Tsuang M.T., Perkins K., Simpson J.C. Physical diseases in schizophrenia and affective disorder. J Clin Psychiatry. 44:1983;42-46.
56. Warkentin T.E., Powling M.J., Hardisty R.M. Measurement of fibrinogen binding to platelets in whole blood by flow cytometry A micromethod for the detection of platelet activation . Br J Haematol. 76:1990;387-394.
57. Wilcox D.A., Wautier J.L., Pidard D., Newman P.J. A single acid substitution flanking the fourth calcium binding domain of alpha IIb prevents maturation of the alpha IIb beta 3 integrin complex. J Biol Chem. 269:1994;4450-4457.
58. Yao J.K., van Kammen D.P. Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 55:1996;21-26.
59. Yao J.K., van Kammen D.P., Gurklis J., Peters J.L. Platelet aggregation and dense granule secretion in schizophrenia. Psychiatry Res. 54:1994;13-24.